311 related articles for article (PubMed ID: 26228531)
1. Human papillomavirus infection and p16 overexpression in oropharyngeal squamous cell carcinoma: a case series from 2010 to 2014.
Donà MG; Spriano G; Pichi B; Rollo F; Laquintana V; Covello R; Pellini R; Giuliani M; Pescarmona E; Benevolo M
Future Microbiol; 2015; 10(8):1283-91. PubMed ID: 26228531
[TBL] [Abstract][Full Text] [Related]
2. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
3. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomas.
Biron VL; Mohamed A; Hendzel MJ; Alan Underhill D; Seikaly H
J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S65-70. PubMed ID: 22569052
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
[TBL] [Abstract][Full Text] [Related]
6. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).
Rodrigo JP; Heideman DA; García-Pedrero JM; Fresno MF; Brakenhoff RH; Díaz Molina JP; Snijders PJ; Hermsen MA
Int J Cancer; 2014 Jan; 134(2):487-92. PubMed ID: 23824638
[TBL] [Abstract][Full Text] [Related]
7. From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas.
Boscolo-Rizzo P; Pawlita M; Holzinger D
Cancer Treat Rev; 2016 Jan; 42():24-9. PubMed ID: 26547133
[TBL] [Abstract][Full Text] [Related]
8. Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival.
Cai C; Chernock RD; Pittman ME; El-Mofty SK; Thorstad WL; Lewis JS
Am J Surg Pathol; 2014 Jun; 38(6):809-15. PubMed ID: 24698966
[TBL] [Abstract][Full Text] [Related]
9. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
[TBL] [Abstract][Full Text] [Related]
10. Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review.
Grønhøj Larsen C; Gyldenløve M; Jensen DH; Therkildsen MH; Kiss K; Norrild B; Konge L; von Buchwald C
Br J Cancer; 2014 Mar; 110(6):1587-94. PubMed ID: 24518594
[TBL] [Abstract][Full Text] [Related]
11. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of Japanese oropharyngeal squamous cell carcinoma positive for human papillomavirus infection.
Nomura F; Sugimoto T; Kitagaki K; Ito T; Kawachi H; Eishi Y; Watanabe K; Igaue M; Shimizu N; Tomita M; Kitamura K; Kishimoto S
Acta Otolaryngol; 2014 Dec; 134(12):1265-74. PubMed ID: 25399886
[TBL] [Abstract][Full Text] [Related]
13. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
[TBL] [Abstract][Full Text] [Related]
14. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
Rooper LM; Gandhi M; Bishop JA; Westra WH
Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
[TBL] [Abstract][Full Text] [Related]
15. The role of high-risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases.
Laco J; Vosmikova H; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Nekvindova J; Vosmik M; Cermakova E; Ryska A
Virchows Arch; 2011 Feb; 458(2):179-87. PubMed ID: 21221634
[TBL] [Abstract][Full Text] [Related]
16. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.
Nwanze J; Cohen C; Schmitt AC; Siddiqui MT
Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661
[TBL] [Abstract][Full Text] [Related]
17. Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival.
Wittekindt C; Gültekin E; Weissenborn SJ; Dienes HP; Pfister HJ; Klussmann JP
Adv Otorhinolaryngol; 2005; 62():72-80. PubMed ID: 15608419
[TBL] [Abstract][Full Text] [Related]
18. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
Jouhi L; Datta N; Renkonen S; Atula T; Mäkitie A; Haglund C; Ahmed A; Syrjänen S; Grénman R; Auvinen E; Lehtonen S; Hagström J
Tumour Biol; 2015 Sep; 36(10):7755-64. PubMed ID: 25941114
[TBL] [Abstract][Full Text] [Related]
19. Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland.
Wells LA; Junor EJ; Conn B; Pattle S; Cuschieri K
J Clin Pathol; 2015 Oct; 68(10):849-52. PubMed ID: 26152733
[TBL] [Abstract][Full Text] [Related]
20. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.
Castellsagué X; Alemany L; Quer M; Halec G; Quirós B; Tous S; Clavero O; Alòs L; Biegner T; Szafarowski T; Alejo M; Holzinger D; Cadena E; Claros E; Hall G; Laco J; Poljak M; Benevolo M; Kasamatsu E; Mehanna H; Ndiaye C; Guimerà N; Lloveras B; León X; Ruiz-Cabezas JC; Alvarado-Cabrero I; Kang CS; Oh JK; Garcia-Rojo M; Iljazovic E; Ajayi OF; Duarte F; Nessa A; Tinoco L; Duran-Padilla MA; Pirog EC; Viarheichyk H; Morales H; Costes V; Félix A; Germar MJ; Mena M; Ruacan A; Jain A; Mehrotra R; Goodman MT; Lombardi LE; Ferrera A; Malami S; Albanesi EI; Dabed P; Molina C; López-Revilla R; Mandys V; González ME; Velasco J; Bravo IG; Quint W; Pawlita M; Muñoz N; de Sanjosé S; Xavier Bosch F;
J Natl Cancer Inst; 2016 Jun; 108(6):djv403. PubMed ID: 26823521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
